Patents Assigned to Brudy Technology, S.L.
  • Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
    Patent number: 10493008
    Abstract: The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: December 3, 2019
    Assignee: BRUDY TECHNOLOGY, S.L.
    Inventors: Joan Carles Domingo Pedrol, Jose Antonio Villegas Garcia
  • Use of docosahexaenoic glycerides for the treatment of tumorous diseases
    Patent number: 9271954
    Abstract: The present invention relates to the use of an oil enriched in docosahexaenoic acid, which is conjugated to triglyceride, for manufacturing a pharmaceutical composition for the treatment of a tumorous disease, said oil being enriched in a concentration of up to 70% by weight in relation to the total weight of said pharmaceutical composition, and said docosahexaenoic acid being in a percentage of at least 50% in relation to the total fatty acids in said oil.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: March 1, 2016
    Assignee: BRUDY TECHNOLOGY, S.L.
    Inventor: Joan Carles Domingo Pedrol
  • Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
    Patent number: 9265745
    Abstract: The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: February 23, 2016
    Assignee: Brudy Technology S.L.
    Inventors: Joan Carles Domingo Pedrol, Jose Antonio Villegas Garcia
  • Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
    Patent number: 9259408
    Abstract: The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: February 16, 2016
    Assignee: Brudy Technology S.L.
    Inventors: Joan Carles Domingo Pedrol, Jose Antonio Villegas Garcia
  • Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative Damage
    Publication number: 20080292681
    Abstract: The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
    Type: Application
    Filed: December 20, 2006
    Publication date: November 27, 2008
    Applicant: Brudy Technology, S.L.
    Inventors: Joan Carles Domingo Pedrol, Jose Antonio Villegas Garcia